Endotronix Revenue and Competitors

Claim your profile

Chicago, IL USA



Total Funding

Estimated Revenue & Valuation

  • Endotronix's estimated annual revenue is currently $52.7M per year.(i)
  • Endotronix received $45.0M in venture funding in September 2018.
  • Endotronix's estimated revenue per employee is $313,750
  • Endotronix's total funding is $129.6M.

Employee Data

  • Endotronix has 168 Employees.(i)
  • Endotronix grew their employee count by 25% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.

keywords:Biotechnology,Enterprise Software,Health It,Healthcare,Medical Devices,Pharmaceuticals


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Endotronix News

2022-04-17 - Implantable Remote Patient Monitoring Devices Market Size ...

KG, Integrated Sensing Systems Inc., Dexcom, Senseonics Holdings Inc., Endotronix Inc., Orthosensor. The report provides a good overview of the key...

2021-03-02 - Endotronix Appoints Industry Veteran Dan Dearen to Board of Directors

LISLE, Ill., March 2, 2021 /PRNewswire/ -- Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the appointment of seasoned medical device industry executive Dan Dearen to its Board of Directors. Mr. Deare ...

2019-10-01 - Endotronix Closes Expanded Series D Financing Round of $70 Million for Heart Failure Solution

LISLE, IL – Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its Series D financing round, bringing the total for the round to $70 million. The expansion syndicate for the LSP-led round includes new i ...

2019-09-08 - Implantable Remote Patient Monitoring Device Market 2019-2025 | Boston Scientific, Endotronix, Inc., Integrated Sensing Systems, Inc., Ludwig Maximilians

Boston Scientific, Endotronix, Inc., Integrated Sensing Systems, Inc., Ludwig Maximilians, niversitat Munich Company, NeuroVista Corporation, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Endotronix Funding

DateAmountRoundLead InvestorsReference
2017-01-10$12.0MCSilicon Valley BankArticle